254 related articles for article (PubMed ID: 10389593)
1. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
[TBL] [Abstract][Full Text] [Related]
2. Beta globin gene inhibition by antisense RNA transcripts.
Xu L; Ferry AE; Monteiro C; Pace BS
Gene Ther; 2000 Mar; 7(5):438-44. PubMed ID: 10694826
[TBL] [Abstract][Full Text] [Related]
3. Correction of sickle cell disease in transgenic mouse models by gene therapy.
Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
[TBL] [Abstract][Full Text] [Related]
4. Multi-ribozyme targeting of human alpha-globin gene expression.
Shen TJ; Ikonomi P; Smith R; Noguchi CT; Ho C
Blood Cells Mol Dis; 1999; 25(5-6):361-73. PubMed ID: 10660485
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules.
Pace BS; Qian X; Ofori-Acquah SF
Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):43-51. PubMed ID: 15040426
[TBL] [Abstract][Full Text] [Related]
6. Interspecies hybrid HbS: complete neutralization of Val6(beta)-dependent polymerization of human beta-chain by pig alpha-chains.
Rao MJ; Malavalli A; Manjula BN; Kumar R; Prabhakaran M; Sun DP; Ho NT; Ho C; Nagel RL; Acharya AS
J Mol Biol; 2000 Jul; 300(5):1389-406. PubMed ID: 10903876
[TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse model of sickle cell disorder.
Greaves DR; Fraser P; Vidal MA; Hedges MJ; Ropers D; Luzzatto L; Grosveld F
Nature; 1990 Jan; 343(6254):183-5. PubMed ID: 2296310
[TBL] [Abstract][Full Text] [Related]
8. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
[TBL] [Abstract][Full Text] [Related]
9. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
Ye L; Chang JC; Lu R; Kan YW
Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
[TBL] [Abstract][Full Text] [Related]
10. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
[TBL] [Abstract][Full Text] [Related]
11. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
Liu J; Timmers AM; Lewin AS; Hauswirth WW
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of sickle cell disease.
Beuzard Y
Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
14. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
[TBL] [Abstract][Full Text] [Related]
15. Design and expression of chimeric U1/ribozyme transgenes.
Abounader R; Montgomery R; Dietz H; Laterra J
Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
[TBL] [Abstract][Full Text] [Related]
16. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme to human TGF-beta1 mRNA inhibits the proliferation of human vascular smooth muscle cells.
Su JZ; Fukuda N; Hu WY; Kanmatsuse K
Biochem Biophys Res Commun; 2000 Nov; 278(2):401-7. PubMed ID: 11097849
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy. Gene gemisch cures sickle cell in mice.
Marshall E
Science; 2001 Dec; 294(5550):2268. PubMed ID: 11743172
[No Abstract] [Full Text] [Related]
19. Deletions within the mouse beta-globin locus control region preferentially reduce beta(min) globin gene expression.
Alami R; Bender MA; Feng YQ; Fiering SN; Hug BA; Ley TJ; Groudine M; Bouhassira EE
Genomics; 2000 Feb; 63(3):417-24. PubMed ID: 10704289
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion.
Andersson BA; Wering ME; Luo HY; Basran RK; Steinberg MH; Smith HP; Chui DH
Eur J Haematol; 2007 Jan; 78(1):82-5. PubMed ID: 17038017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
